{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:52:02Z","timestamp":1791168722284,"version":"4.1.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/yco.0b013e32833b027e","type":"journal-article","created":{"date-parts":[[2010,5,25]],"date-time":"2010-05-25T15:34:47Z","timestamp":1274801687000},"page":"304-310","source":"Crossref","is-referenced-by-count":39,"title":["Treatment of early-onset schizophrenia"],"prefix":"10.1097","volume":"23","author":[{"given":"Anand K","family":"Mattai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoshel K","family":"Lenroot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-3-20210206","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00004583-199406000-00003","article-title":"Looking for childhood-onset schizophrenia: the first 71 cases screened","volume":"33","author":"McKenna","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R4-3-20210206","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0193-953X(18)30657-9","article-title":"Childhood schizophrenia: a review and comparison with adult-onset schizophrenia","volume":"8","author":"Beitchman","year":"1985","journal-title":"Psychiatr Clin North Am"},{"key":"R5-3-20210206","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02190731","article-title":"Special issue \u2018Schizophrenia in Childhood and Adolescence\u2019 [editorial]","volume":"245","author":"Hafner","year":"1995","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R6-3-20210206","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0006-3223(99)00231-0","article-title":"Childhood-onset schizophrenia: rare but worth studying","volume":"46","author":"Nicolson","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R7-3-20210206","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11920-005-0001-z","article-title":"The neurodevelopmental model of schizophrenia: what can very early onset cases tell us?","volume":"7","author":"Rapoport","year":"2005","journal-title":"Curr Psychiatry Rep"},{"key":"R8-3-20210206","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/cap.2005.15.395","article-title":"Childhood-onset schizotypal disorder: a follow-up study and comparison with childhood-onset schizophrenia","volume":"15","author":"Asarnow","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R9-3-20210206","first-page":"53","article-title":"Transcranial direct current stimulation: a new tool for human cognitive neuroscience","volume":"61","author":"Tanaka","year":"2009","journal-title":"Brain Nerve"},{"key":"R10-3-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u2018just the facts\u2019 4: clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr Res"},{"key":"R11-3-20210206","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.psc.2009.08.005","article-title":"Management of schizophrenia with suicide risk","volume":"32","author":"Roy","year":"2009","journal-title":"Psychiatr Clin North Am"},{"key":"R12-3-20210206","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/00023210-200620100-00005","article-title":"Children with schizophrenia: clinical picture and pharmacological treatment","volume":"20","author":"Masi","year":"2006","journal-title":"CNS Drugs"},{"key":"R13-3-20210206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004583-200003000-00016","article-title":"Psychosis in a pediatric mood and anxiety disorders clinic: phenomenology and correlates","volume":"39","author":"Ulloa","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 1","key":"R14-3-20210206","doi-asserted-by":"crossref","first-page":"I13","DOI":"10.1007\/PL00010686","article-title":"Early onset psychotic disorders: diagnostic stability and clinical characteristics","volume":"8","author":"McClellan","year":"1999","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R15-3-20210206","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2007.12.468","article-title":"Adjunctive psychosocial therapies for the treatment of schizophrenia","volume":"100","author":"Patterson","year":"2008","journal-title":"Schizophr Res"},{"key":"R16-3-20210206","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1176\/appi.ajp.2007.07060906","article-title":"A meta-analysis of cognitive remediation in schizophrenia","volume":"164","author":"McGurk","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R17-3-20210206","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bmj.38565.415000.E01","article-title":"A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness","volume":"331","author":"Petersen","year":"2005","journal-title":"BMJ"},{"key":"R18-3-20210206","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1176\/ps.2009.60.11.1468","article-title":"Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial","volume":"60","author":"Eack","year":"2009","journal-title":"Psychiatr Serv"},{"key":"R19-3-20210206","first-page":"99","article-title":"A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients","volume":"19","author":"Pool","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"key":"R20-3-20210206","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1176\/ajp.141.3.440","article-title":"Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents","volume":"141","author":"Realmuto","year":"1984","journal-title":"Am J Psychiatry"},{"key":"R21-3-20210206","first-page":"183","article-title":"Haloperidol in schizophrenic children: early findings from a study in progress","volume":"28","author":"Spencer","year":"1992","journal-title":"Psychopharmacol Bull"},{"key":"R22-3-20210206","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/104454603322572697","article-title":"Clozapine-induced neutropenia in children: management with lithium carbonate","volume":"13","author":"Sporn","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R23-3-20210206","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.63.7.721","article-title":"Childhood-onset schizophrenia: a double-blind, randomized clozapine-olanzapine comparison","volume":"63","author":"Shaw","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R24-3-20210206","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biopsych.2007.04.043","article-title":"Clozapine and high-dose olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.","volume":"63","author":"Kumra","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R25-3-20210206","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hup.982","article-title":"Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents","volume":"23","author":"Kim","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"R26-3-20210206","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study","volume":"165","author":"Sikich","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R27-3-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0029-1202266","article-title":"Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review","volume":"42","author":"Bachmann","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"R28-3-20210206","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/cap.2008.0144","article-title":"A 6-week, andomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia","volume":"19","author":"Haas","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R29-3-20210206","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11920-006-0070-7","article-title":"Guidelines for clinical treatment of early course schizophrenia","volume":"8","author":"Keshavan","year":"2006","journal-title":"Curr Psychiatry Rep"},{"key":"R30-3-20210206","first-page":"649","article-title":"The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians","volume":"23","author":"Naber","year":"2009","journal-title":"CNS Drugs"},{"key":"R31-3-20210206","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0031-3955(05)70070-5","article-title":"The antipsychotics: a pediatric perspective","volume":"45","author":"Findling","year":"1998","journal-title":"Pediatr Clin North Am"},{"key":"R32-3-20210206","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1517\/14656566.9.12.2053","article-title":"Child and adolescent schizophrenia: pharmacological approaches","volume":"9","author":"Madaan","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"R33-3-20210206","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/schbul\/sbm109","article-title":"Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia","volume":"34","author":"Kumra","year":"2008","journal-title":"Schizophr Bull"},{"key":"R35-3-20210206","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14656566.9.3.459","article-title":"Clozapine use in children and adolescents","volume":"9","author":"Gogtay","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"R36-3-20210206","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1542\/peds.2007-2008","article-title":"Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom","volume":"121","author":"Rani","year":"2008","journal-title":"Pediatrics"},{"key":"R37-3-20210206","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1017\/S0033291709005455","article-title":"Second-generation antipsychotics for schizophrenia: can we resolve the conflict?","volume":"39","author":"Leucht","year":"2009","journal-title":"Psychol Med"},{"key":"R38-3-20210206","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/CHI.0b013e3180691779","article-title":"Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods","volume":"46","author":"McClellan","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R39-3-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1176\/ps.2008.59.5.507","article-title":"Who are the new users of antipsychotic medications?","volume":"59","author":"Domino","year":"2008","journal-title":"Psychiatr Serv"},{"key":"R40-3-20210206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chc.2005.08.007","article-title":"Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents","volume":"15","author":"Correll","year":"2006","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"R41-3-20210206","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.932","article-title":"Adverse events in children and adolescents treated with antipsychotic medications","volume":"23","author":"Jerrell","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"R42-3-20210206","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"R43-3-20210206","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4088\/JCP.v69n0717","article-title":"Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics","volume":"69","author":"Fraguas","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R44-3-20210206","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00702-008-0105-9","article-title":"Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone","volume":"115","author":"Fleischhaker","year":"2008","journal-title":"J Neural Transm"},{"key":"R45-3-20210206","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09540260801889179","article-title":"Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients","volume":"20","author":"Correll","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"R46-3-20210206","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euroneuro.2009.04.008","article-title":"Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns","volume":"19","author":"Vitiello","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"R47-3-20210206","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10398560801958549","article-title":"Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists","volume":"16","author":"Walter","year":"2008","journal-title":"Australas Psychiatry"},{"issue":"Suppl 4","key":"R48-3-20210206","first-page":"26","article-title":"Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents","volume":"69","author":"Correll","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R49-3-20210206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1092852900015959","article-title":"Acute and long-term adverse effects of antipsychotics","volume":"12","author":"Correll","year":"2007","journal-title":"CNS Spectr"},{"key":"R50-3-20210206","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4088\/JCP.v69n0422","article-title":"Antipsychotic polypharmacy, part 1: shotgun approach or targeted cotreatment?","volume":"69","author":"Correll","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R51-3-20210206","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1524-4733.2008.00500.x","article-title":"Health-care costs of pediatric clients developing adverse events during treatment with antipsychotics.","volume":"12","author":"Jerrell","year":"2009","journal-title":"Value Health"},{"key":"R52-3-20210206","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","article-title":"Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America","volume":"65","author":"Cannon","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R53-3-20210206","first-page":"161","article-title":"The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe","volume":"4","author":"Klosterkotter","year":"2005","journal-title":"World Psychiatry"},{"key":"R54-3-20210206","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00048670903107625","article-title":"Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics","volume":"43","author":"Phillips","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"R55-3-20210206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/YCO.0b013e328324b687","article-title":"Intervention in the at-risk state to prevent transition to psychosis","volume":"22","author":"Ruhrmann","year":"2009","journal-title":"Curr Opin Psychiatry"},{"key":"R56-3-20210206","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/schbul\/sbn072","article-title":"Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state.","volume":"36","author":"Schultze-Lutter","year":"2010","journal-title":"Schizophr Bull"},{"key":"R57-3-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2007.05.018","article-title":"Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis","volume":"96","author":"Phillips","year":"2007","journal-title":"Schizophr Res"},{"key":"R58-3-20210206","doi-asserted-by":"crossref","first-page":"s88","DOI":"10.1192\/bjp.191.51.s88","article-title":"Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis","volume":"51","author":"Ruhrmann","year":"2007","journal-title":"Br J Psychiatry Suppl"},{"key":"R59-3-20210206","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4088\/JCP.08r04472","article-title":"Intervention in individuals at ultra high risk for psychosis: a review and future directions","volume":"70","author":"McGorry","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R60-3-20210206","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/S0140-6736(07)61732-2","article-title":"Can antidepressants prevent psychosis?","volume":"370","author":"Fusar-Poli","year":"2007","journal-title":"Lancet"},{"key":"R61-3-20210206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2006.05.007","article-title":"Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R62-3-20210206","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/schbul\/sbm015","article-title":"Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?","volume":"33","author":"Yung","year":"2007","journal-title":"Schizophr Bull"},{"key":"R63-3-20210206","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.5694\/j.1326-5377.2007.tb01335.x","article-title":"Clinical staging: a heuristic model for psychiatry and youth mental health","volume":"187","author":"McGorry","year":"2007","journal-title":"Med J Aust"},{"key":"R64-3-20210206","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/schbul\/sbm157","article-title":"Longitudinal brain changes in early-onset psychosis","volume":"34","author":"Arango","year":"2008","journal-title":"Schizophr Bull"},{"key":"R65-3-20210206","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2009.10.018","article-title":"Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia.","volume":"116","author":"Mattai","year":"2010","journal-title":"Schizophr Res"},{"key":"R66-3-20210206","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1017\/S1461145707008309","article-title":"rTMS strategies for the study and treatment of schizophrenia: a review","volume":"11","author":"Stanford","year":"2008","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Current Opinion in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/YCO.0b013e32833b027e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:20:23Z","timestamp":1786040423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001504-201007000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/yco.0b013e32833b027e","relation":{},"ISSN":["0951-7367"],"issn-type":[{"value":"0951-7367","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}